Diagnostic and therapeutic challenges.
McDonald
H R
HR
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis; D001474:Bartonella Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D018416:Bartonella henselae / Q000235:genetics / Q000276:immunology; D018413:Bartonella quintana / Q000235:genetics / Q000276:immunology; D004269:DNA, Bacterial / Q000032:analysis; D003937:Diagnosis, Differential; D004318:Doxycycline / Q000627:therapeutic use; D015818:Eye Infections, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D015356:Retinal Artery Occlusion / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D012173:Retinitis / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D004269:DNA, Bacterial; D004318:Doxycycline